Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone marrow monocytes sustain NK cell-poiesis during non-alcoholic steatohepatitis. | Cell Rep | 2024 | 38217855 | PubTator, text mining | PubMed |
| Molecular origin and biological effects of exercise mimetics. | J Exerc Sci Fit | 2024 | 38187084 | PubTator, text mining | PubMed |
| Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. | Exp Mol Med | 2024 | 38172594 | PubTator, text mining | PubMed |
| Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral Therapy. | Pac Symp Biocomput | 2024 | 38160309 | PubTator, text mining | PubMed |
| Estimation of serum and tissue level of interleukin-15 (IL-15) and IL-15 receptor alpha (IL-15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study. | Photodermatol Photoimmunol Photomed | 2024 | 38157308 | PubTator, text mining | PubMed |
| Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling. | Cell Mol Gastroenterol Hepatol | 2024 | 37879404 | PubTator, text mining | PubMed |
| DNA methylation drives a new path in gastric cancer early detection: Current impact and prospects. | Genes Dis | 2024 | 37692483 | PubTator, text mining | PubMed |
| NK cell-based tumor immunotherapy. | Bioact Mater | 2024 | 37601277 | PubTator, text mining | PubMed |
| Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. | Mol Cell Biochem | 2024 | 37016182 | PubTator, text mining | PubMed |
| Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing. | Front Immunol | 2023 | 38283342 | PubTator, text mining | PubMed |
| Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma. | Front Immunol | 2023 | 38268923 | PubTator, text mining | PubMed |
| Drug resistance in glioblastoma: from chemo- to immunotherapy. | Cancer Drug Resist | 2023 | 38239396 | PubTator, text mining | PubMed |
| Interleukin-15 responses to acute and chronic exercise in adults: a systematic review and meta-analysis. | Front Immunol | 2023 | 38235143 | PubTator, text mining | PubMed |
| Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation. | Front Immunol | 2023 | 38235129 | PubTator, text mining | PubMed |
| Long COVID: Molecular Mechanisms and Detection Techniques. | Int J Mol Sci | 2023 | 38203577 | PubTator, text mining | PubMed |
| Biological, pathological, and multifaceted therapeutic functions of exosomes to target cancer. | Oncol Res | 2023 | 38188673 | PubTator, text mining | PubMed |
| Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach. | Oncol Res | 2023 | 38186568 | PubTator, text mining | PubMed |
| Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 38156400 | PubTator, text mining | PubMed |
| Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer. | Genes (Basel) | 2023 | 38136994 | PubTator, text mining | PubMed |
| Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma. | Cancers (Basel) | 2023 | 38136398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=9